-
1
-
-
0036840022
-
Therapeutic use of botulinum toxins: Background and history
-
12569958 10.1097/00002508-200211001-00002
-
Setler P (2002) Therapeutic use of botulinum toxins: background and history. Clin J Pain 18:S119-S124
-
(2002)
Clin J Pain
, vol.18
-
-
Setler, P.1
-
2
-
-
0034651211
-
Uses of botulinum toxin injection in medicine today
-
10634738 10.1136/bmj.320.7228.161
-
Münchau A, Bhatia KP (2000) Uses of botulinum toxin injection in medicine today. BMJ 320(7228):161-165
-
(2000)
BMJ
, vol.320
, Issue.7228
, pp. 161-165
-
-
Münchau, A.1
Bhatia, K.P.2
-
3
-
-
68249128112
-
Botox therapy for ischaemic digits
-
19568080 10.1097/PRS.0b013e3181a80576 1:CAS:528:DC%2BD1MXnvVyjtbw%3D
-
Neumeister MW et al (2009) Botox therapy for ischaemic digits. Plast Reconstr Surg 124:191-200
-
(2009)
Plast Reconstr Surg
, vol.124
, pp. 191-200
-
-
Neumeister, M.W.1
-
4
-
-
60849135398
-
Botulinum toxin type A: A treatment option for digital ischaemia in patients with Raynaud's phenomenon
-
Fregene A et al (2009) Botulinum toxin type A: a treatment option for digital ischaemia in patients with Raynaud's phenomenon. J Hand Surg 34A:446-452
-
(2009)
J Hand Surg
, vol.34
, pp. 446-452
-
-
Fregene, A.1
-
5
-
-
33847017781
-
Management of vasospastic disorders with botulinum toxin A
-
17255677 10.1097/01.prs.0000244860.00674.57
-
Van Beek AL et al (2007) Management of vasospastic disorders with botulinum toxin A. Plast Reconstr Surg 119:217-226
-
(2007)
Plast Reconstr Surg
, vol.119
, pp. 217-226
-
-
Van Beek, A.L.1
-
6
-
-
2142704322
-
Botulinum toxin in the treatment of Raynaud's phenomenon: A pilot study
-
10.1111/j.1365-2362.2004.01324.x 1:STN:280:DC%2BD2c7ptFWgsA%3D%3D
-
Sycha T et al (2004) Botulinum toxin in the treatment of Raynaud's phenomenon: a pilot study. Euro J Clin Invest 34:312-313
-
(2004)
Euro J Clin Invest
, vol.34
, pp. 312-313
-
-
Sycha, T.1
-
7
-
-
0026795115
-
Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes: Clues to the locus of action
-
1356988 1:CAS:528:DyaK38Xls1GltLc%3D
-
McMahon HT et al (1992) Tetanus toxin and botulinum toxins type A and B inhibit glutamate, gamma-aminobutyric acid, aspartate, and met-enkephalin release from synaptosomes: clues to the locus of action. J Biol Chem 267:21338-21343
-
(1992)
J Biol Chem
, vol.267
, pp. 21338-21343
-
-
McMahon, H.T.1
-
8
-
-
65249095310
-
Sympathetic block with botulinum toxin to treat complex regional pain syndrome
-
19334078 10.1002/ana.21601 1:CAS:528:DC%2BD1MXltVOktL0%3D
-
Carroll I et al (2009) Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol 65(3):348-351
-
(2009)
Ann Neurol
, vol.65
, Issue.3
, pp. 348-351
-
-
Carroll, I.1
-
9
-
-
0036840028
-
A foculsed review on the use of botulinum toxins for neuropathic pain
-
12569966 10.1097/00002508-200211001-00010
-
Argoff CE (2002) A foculsed review on the use of botulinum toxins for neuropathic pain. Clin J Pain 18(6):S177-S181
-
(2002)
Clin J Pain
, vol.18
, Issue.6
-
-
Argoff, C.E.1
-
10
-
-
33747423661
-
Efficacy of botulinum toxin type a in the relief of Carpal tunnel syndrome: A preliminary experience
-
10.2165/00044011-200626090-00004 1:CAS:528:DC%2BD28XpvFOku7o%3D
-
Tsai CP et al (2006) Efficacy of botulinum toxin type a in the relief of Carpal tunnel syndrome: a preliminary experience. Clin Drug Invest 26(9):511-515
-
(2006)
Clin Drug Invest
, vol.26
, Issue.9
, pp. 511-515
-
-
Tsai, C.P.1
|